Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade
Background: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective serotonin reuptake inhibitors (SSRIs) and NPS signali...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/5/631 |
_version_ | 1797496836012900352 |
---|---|
author | Aneta Piwowarczyk-Nowak Artur Pałasz Aleksandra Suszka-Świtek Iwona Błaszczyk Katarzyna Bogus Barbara Łasut-Szyszka Marek Krzystanek John J. Worthington |
author_facet | Aneta Piwowarczyk-Nowak Artur Pałasz Aleksandra Suszka-Świtek Iwona Błaszczyk Katarzyna Bogus Barbara Łasut-Szyszka Marek Krzystanek John J. Worthington |
author_sort | Aneta Piwowarczyk-Nowak |
collection | DOAJ |
description | Background: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective serotonin reuptake inhibitors (SSRIs) and NPS signaling, especially in the context of adult neurogenesis and the expression of noncanonical stress-related neuropeptides such as neuromedin U (NMU). The present work therefore focused on immunoexpression of neuromedin U receptor 2 (NMUR2) and doublecortin (DCX) in the rat hippocampus after acute treatment with escitalopram and in combination with selective neuropeptide S receptor (NPSR) blockade. Methods: Studies were carried out on adult, male Sprague-Dawley rats that were divided into five groups: animals injected with saline (control) and experimental individuals treated with escitalopram (at single dose 10 mg/kg daily), escitalopram + SHA-68, a selective NPSR antagonist (at single dose 40 mg/kg), SHA-68 alone, and corresponding vehicle control. All animals were sacrificed under halothane anaesthesia. The whole hippocampi were quickly excised, fixed, and finally sliced for general qualitative immunohistochemical assessment of the NPSR and NMUR2 expression. The number of immature neurons was enumerated using immunofluorescent detection of doublecortin (DCX) expression within the subgranular zone (SGZ). Results: Acute escitalopram administration affects the number of DCX and NMUR2-expressing cells in the adult rat hippocampus. A decreased number of DCX-expressing neuroblasts after treatment with escitalopram was augmented by SHA-68 coadministration. Conclusions: Early pharmacological effects of escitalopram may be at least partly connected with local NPSR-related alterations of neuroblast maturation in the rat hippocampus. Escitalopram may affect neuropeptide and DCX-expression starting even from the first dose. Adult neurogenesis may be regulated via paracrine neuropeptide S and NMU-related signaling. |
first_indexed | 2024-03-10T03:09:13Z |
format | Article |
id | doaj.art-221881a91500498097a209f70a2eaa3c |
institution | Directory Open Access Journal |
issn | 1424-8247 |
language | English |
last_indexed | 2024-03-10T03:09:13Z |
publishDate | 2022-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Pharmaceuticals |
spelling | doaj.art-221881a91500498097a209f70a2eaa3c2023-11-23T12:35:43ZengMDPI AGPharmaceuticals1424-82472022-05-0115563110.3390/ph15050631Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor BlockadeAneta Piwowarczyk-Nowak0Artur Pałasz1Aleksandra Suszka-Świtek2Iwona Błaszczyk3Katarzyna Bogus4Barbara Łasut-Szyszka5Marek Krzystanek6John J. Worthington7Department of Anatomy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandDepartment of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752 Katowice, PolandCenter for Translational Research and Molecular Biology of Cancer, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, PolandClinic of Psychiatric Rehabilitation, Department of Psychiatry and Psychotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia, ul. Ziolowa 45/47, 40-635 Katowice, PolandDivision of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster LA1 4YG, UKBackground: Neuropeptide S (NPS) is a multifunctional regulatory factor that exhibits a potent anxiolytic activity in animal models. However, there are no reports dealing with the potential molecular interactions between the activity of selective serotonin reuptake inhibitors (SSRIs) and NPS signaling, especially in the context of adult neurogenesis and the expression of noncanonical stress-related neuropeptides such as neuromedin U (NMU). The present work therefore focused on immunoexpression of neuromedin U receptor 2 (NMUR2) and doublecortin (DCX) in the rat hippocampus after acute treatment with escitalopram and in combination with selective neuropeptide S receptor (NPSR) blockade. Methods: Studies were carried out on adult, male Sprague-Dawley rats that were divided into five groups: animals injected with saline (control) and experimental individuals treated with escitalopram (at single dose 10 mg/kg daily), escitalopram + SHA-68, a selective NPSR antagonist (at single dose 40 mg/kg), SHA-68 alone, and corresponding vehicle control. All animals were sacrificed under halothane anaesthesia. The whole hippocampi were quickly excised, fixed, and finally sliced for general qualitative immunohistochemical assessment of the NPSR and NMUR2 expression. The number of immature neurons was enumerated using immunofluorescent detection of doublecortin (DCX) expression within the subgranular zone (SGZ). Results: Acute escitalopram administration affects the number of DCX and NMUR2-expressing cells in the adult rat hippocampus. A decreased number of DCX-expressing neuroblasts after treatment with escitalopram was augmented by SHA-68 coadministration. Conclusions: Early pharmacological effects of escitalopram may be at least partly connected with local NPSR-related alterations of neuroblast maturation in the rat hippocampus. Escitalopram may affect neuropeptide and DCX-expression starting even from the first dose. Adult neurogenesis may be regulated via paracrine neuropeptide S and NMU-related signaling.https://www.mdpi.com/1424-8247/15/5/631escitalopramneuropeptide Shippocampusneuromedin UNPSRNMUR2 |
spellingShingle | Aneta Piwowarczyk-Nowak Artur Pałasz Aleksandra Suszka-Świtek Iwona Błaszczyk Katarzyna Bogus Barbara Łasut-Szyszka Marek Krzystanek John J. Worthington Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade Pharmaceuticals escitalopram neuropeptide S hippocampus neuromedin U NPSR NMUR2 |
title | Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade |
title_full | Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade |
title_fullStr | Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade |
title_full_unstemmed | Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade |
title_short | Effect of Escitalopram on the Number of DCX-Positive Cells and NMUR2 Receptor Expression in the Rat Hippocampus under the Condition of NPSR Receptor Blockade |
title_sort | effect of escitalopram on the number of dcx positive cells and nmur2 receptor expression in the rat hippocampus under the condition of npsr receptor blockade |
topic | escitalopram neuropeptide S hippocampus neuromedin U NPSR NMUR2 |
url | https://www.mdpi.com/1424-8247/15/5/631 |
work_keys_str_mv | AT anetapiwowarczyknowak effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT arturpałasz effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT aleksandrasuszkaswitek effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT iwonabłaszczyk effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT katarzynabogus effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT barbarałasutszyszka effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT marekkrzystanek effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade AT johnjworthington effectofescitalopramonthenumberofdcxpositivecellsandnmur2receptorexpressionintherathippocampusundertheconditionofnpsrreceptorblockade |